Cited 5 times in
Axillary response according to neoadjuvant single or dual human epidermal growth factor receptor 2 (HER2) blockade in clinically node-positive, HER2-positive breast cancer
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.